Humana Inc. Shows Mixed Results in Guru Fundamental Report

Humana Inc. receives a 60% rating from the Shareholder Yield Investor model. While it passes some criteria, it fails in net payout yield and shareholder yield, indicating a mixed outlook. Investors may want to consider these factors before making decisions.

Date: 17-03-2025

AI Rating: 5

**Overview of Humana Inc. Performance** Humana Inc., identified as HUM, has been evaluated under the Shareholder Yield Investor model which emphasizes cash returns to shareholders. With a rating of 60%, the stock showcases potential but also areas of concern that may impact stock prices. **Key Criteria Analysis** According to the report, Humana passes several significant criteria including: - **Universe**: PASS - **Quality and Debt**: PASS - **Valuation**: PASS - **Relative Strength**: PASS However, it notably **fails** the following criteria: - **Net Payout Yield**: FAIL - **Shareholder Yield**: FAIL The failures in 'Net Payout Yield' and 'Shareholder Yield' may raise concerns for investors focused on returns. This could lead to decreased interest from those prioritizing cash returns, potentially lowering stock prices. Additionally, while the score of 60% suggests that the stock has its strong points, it does imply that it has not met the expectations that would typically reflect a higher level of investor confidence. A higher score would indicate a more compelling investment opportunity, so the current rating might not draw significant investment unless improvements are made in the failing areas. **Future Implications** If the company can address its shortcomings in net payout and shareholder yield, it may positively impact investor sentiment and, in turn, the stock price. However, until those factors are corrected, investors might view Humana as a less favorable option relative to its peers in the healthcare industry.

Stocks: HUM